Zai Lab Limited (ZLAB)
(Delayed Data from NSDQ)
$21.85 USD
+0.76 (3.60%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $22.33 +0.48 (2.20%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for Zai Lab Limited Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 806 | 1,008 | 1,409 | 1,187 | 276 |
Receivables | 59 | 40 | 47 | 5 | 4 |
Notes Receivable | 6 | 9 | 7 | 0 | 0 |
Inventories | 45 | 32 | 19 | 13 | 6 |
Other Current Assets | 23 | 36 | 18 | 11 | 7 |
Total Current Assets | 940 | 1,124 | 1,501 | 1,216 | 292 |
Net Property & Equipment | 54 | 58 | 43 | 29 | 21 |
Investments & Advances | 9 | 6 | 16 | 1 | 2 |
Other Non-Current Assets | 0 | 0 | 24 | 22 | 14 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 16 | 8 | 10 | 9 | 9 |
Deposits & Other Assets | 2 | 4 | 3 | 2 | 1 |
Total Assets | 1,036 | 1,220 | 1,610 | 1,298 | 355 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 113 | 66 | 126 | 63 | 23 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 6 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 83 | 67 | 61 | 30 | 13 |
Total Current Liabilities | 203 | 140 | 193 | 98 | 47 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 29 | 21 | 27 | 17 | 3 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 240 | 175 | 230 | 128 | 60 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,975 | 2,893 | 2,826 | 1,897 | 735 |
Retained Earnings | -2,196 | -1,861 | -1,418 | -714 | -445 |
Other Equity | 38 | 26 | -24 | -15 | 5 |
Treasury Stock | 21 | 12 | 4 | 0 | 0 |
Total Shareholder's Equity | 796 | 1,046 | 1,380 | 1,169 | 295 |
Total Liabilities & Shareholder's Equity | 1,036 | 1,220 | 1,610 | 1,298 | 355 |
Total Common Equity | 796 | 1,046 | 1,380 | 1,169 | 295 |
Shares Outstanding | 98.80 | 97.90 | 96.40 | NA | 58.10 |
Book Value Per Share | 8.06 | 10.68 | 14.31 | -0.01 | 5.07 |
Fiscal Year End for Zai Lab Limited Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 730 | 751 | 806 | 820 | 875 |
Receivables | 70 | 60 | 59 | 42 | 47 |
Notes Receivable | 8 | 15 | 6 | 24 | 21 |
Inventories | 42 | 38 | 45 | 44 | 36 |
Other Current Assets | 20 | 24 | 23 | 30 | 38 |
Total Current Assets | 870 | 889 | 940 | 960 | 1,018 |
Net Property & Equipment | 51 | 52 | 54 | 55 | 56 |
Investments & Advances | 4 | 14 | 9 | 4 | 5 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 47 | 15 | 16 | 5 | 5 |
Deposits & Other Assets | 3 | 3 | 2 | 3 | 4 |
Total Assets | 987 | 988 | 1,036 | 1,044 | 1,106 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 127 | 88 | 113 | 55 | 67 |
Current Portion Long-Term Debt | 70 | 48 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 47 | 48 | 83 | 63 | 59 |
Total Current Liabilities | 252 | 192 | 203 | 125 | 133 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 25 | 26 | 29 | 28 | 29 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 283 | 226 | 240 | 163 | 174 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 3,012 | 2,993 | 2,975 | 2,954 | 2,932 |
Retained Earnings | -2,330 | -2,249 | -2,196 | -2,101 | -2,031 |
Other Equity | 43 | 39 | 38 | 48 | 52 |
Treasury Stock | 21 | 21 | 21 | 21 | 21 |
Total Shareholder's Equity | 704 | 762 | 796 | 881 | 932 |
Total Liabilities & Shareholder's Equity | 987 | 988 | 1,036 | 1,044 | 1,106 |
Total Common Equity | 704 | 762 | 796 | 881 | 932 |
Shares Outstanding | 99.60 | 99.20 | 98.80 | 98.80 | 98.30 |
Book Value Per Share | 7.07 | 7.68 | 8.06 | 8.92 | 9.48 |